Trial intelligence / Profile preview

Cetuximab plus capecitabine maintenance after first-line cetuximab chemotherapy in RAS wild-type left-sided metastatic colorectal cancer

ChiCTR1800019831Phase 2Recruiting

Sponsor

Affiliated Hospital of Southwest Medical University

Start

Dec 2018

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1